bf/NASDAQ:RETA_icon.jpeg

NASDAQ:RETA

Reata Pharmaceuticals, Inc.

  • Stock

USD

Last Close

172.32

25/09 20:00

Market Cap

6.57B

Beta: 1.53

Volume Today

1.91M

Avg: 1.45M

PE Ratio

−81.11

PFCF: −26.32

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Market
  • website

    www.reatapharma.com
  • ipo date

    May 26, 2016
  • full time employees

    321
  • currency

    USD

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the t...Show More

Earnings

Earnings per Share (Estimate*)

-22462014-12-312017-03-032019-02-282021-03-012023-02-24

Revenue (Estimate*)

20M40M60M80M100M120M140M2014-12-312017-03-032019-02-282021-03-012023-02-24

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.